Tim McCarthy | IR, LifeSci Advisors |
Sergio Traversa | CEO |
Maged Shenouda | CFO |
Andrew Tsai | Jefferies |
Andrea Tan | Goldman Sachs |
Joon Lee | Truist Securities |
Yatin Suneja | Guggenheim |
Jay Olson | Oppenheimer |
Greetings, and welcome to the Relmada Therapeutics Fourth Quarter and Full Year 2021 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Tim McCarthy of LifeSci Advisors.